MedPath

Pelvalon, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:3

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

Pursuit: Real World Use of the Eclipse System

Not Applicable
Conditions
Fecal Incontinence
First Posted Date
2019-05-07
Last Posted Date
2021-03-11
Lead Sponsor
Pelvalon, Inc.
Target Recruit Count
150
Registration Number
NCT03940573
Locations
🇺🇸

The American Association of Female Pelvic Medicine, Agoura Hills, California, United States

🇺🇸

The Ob-Gyn and Incontinence Center, Arcadia, California, United States

🇺🇸

Long Beach Urogynecology, Long Beach, California, United States

and more 3 locations

LIBERATE - PRO: Eclipse™ System Registry

Completed
Conditions
Fecal Incontinence
Bowel Dysfunction
Bowel Incontinence
Accidental Bowel Leakage
First Posted Date
2017-01-23
Last Posted Date
2020-01-28
Lead Sponsor
Pelvalon, Inc.
Target Recruit Count
17
Registration Number
NCT03028636
Locations
🇺🇸

Pelvalon, Inc., Sunnyvale, California, United States

A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women

Not Applicable
Completed
Conditions
Fecal Incontinence
First Posted Date
2015-04-29
Last Posted Date
2019-09-24
Lead Sponsor
Pelvalon, Inc.
Target Recruit Count
137
Registration Number
NCT02428595
Locations
🇺🇸

University of Alabama, Birmingham, Alabama, United States

🇺🇸

Massachusetts General Hospital (MGH), Boston, Massachusetts, United States

🇺🇸

University of New Mexico, Albuquerque, New Mexico, United States

and more 8 locations

A Clinical Evaluation of a Vaginal Bowel Control System for the Treatment of Fecal Incontinence in Women (LIFE)

Not Applicable
Completed
Conditions
Fecal Incontinence
First Posted Date
2012-08-02
Last Posted Date
2015-05-27
Lead Sponsor
Pelvalon, Inc.
Target Recruit Count
61
Registration Number
NCT01655498
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.